Stockscreener 앱 받기
9.14
3.23%
0.31
전일 마감가:
$8.83
열려 있는:
$8.81
하루 거래량:
147.98K
Relative Volume:
0.10
시가총액:
$279.45M
수익:
-
순이익/손실:
$-29.25M
주가수익비율:
-7.7066
EPS:
-1.186
순현금흐름:
$-22.80M
1주 성능:
-3.95%
1개월 성능:
+4.53%
6개월 성능:
+114.47%
1년 성능:
+194.98%
1일 변동 폭
$8.81
$9.19
1주일 범위
$8.79
$9.95
52주 변동 폭
$1.73
$10.43
Sagimet Biosciences Inc Stock (SGMT) Company Profile
명칭
Sagimet Biosciences Inc
전화
(650) 561-8600
주소
155 BOVET RD., SUITE 303, SAN MATEO
SGMT을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
SGMT
Sagimet Biosciences Inc
|
9.11 | 304.57M | 0 | -29.25M | -22.80M | -1.186 |
|
VRTX
Vertex Pharmaceuticals Inc
|
465.83 | 121.30B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.57 | 61.60B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
322.60 | 41.17B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
566.67 | 34.35B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
293.31 | 27.29B | 3.81B | -644.79M | -669.77M | -6.24 |
Sagimet Biosciences Inc Stock (SGMT) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-06 | 개시 | Oppenheimer | Outperform |
| 2024-11-12 | 개시 | UBS | Buy |
| 2024-06-28 | 다운그레이드 | Goldman | Buy → Neutral |
| 2024-05-02 | 개시 | H.C. Wainwright | Buy |
| 2024-03-25 | 개시 | Leerink Partners | Outperform |
| 2023-08-08 | 개시 | Goldman | Buy |
| 2023-08-08 | 개시 | JMP Securities | Mkt Outperform |
| 2023-08-08 | 개시 | Piper Sandler | Overweight |
| 2023-08-08 | 개시 | TD Cowen | Outperform |
모두보기
Sagimet Biosciences Inc 주식(SGMT)의 최신 뉴스
How Sagimet Biosciences Inc. stock performs during market volatilityLow Volatility High Yield Stocks - Newser
Is Sagimet Biosciences Inc. a good long term investmentOutstanding capital growth - jammulinksnews.com
What drives Sagimet Biosciences Inc. stock priceTremendous growth opportunities - jammulinksnews.com
Sagimet Biosciences Inc. Stock Analysis and ForecastOutstanding stock performance - Autocar Professional
What analysts say about Sagimet Biosciences Inc. stockUnstoppable investment returns - Autocar Professional
what makes sagimet biosciences inc. stock price move sharplyShort Squeeze Radar - Newser
We Think Sagimet Biosciences (NASDAQ:SGMT) Can Afford To Drive Business Growth - Yahoo Finance
Why Sagimet Biosciences Inc. stock attracts strong analyst attentionRisk Limited High Gain Trades - Newser
What makes Sagimet Biosciences Inc. stock price move sharplyFree Stock Market Group - Newser
Is Sagimet Biosciences, Inc. technically bullish or bearish? - MarketsMojo
Eyes on Asia: AstraZeneca, NextCure, Sagimet Biosciences - BioXconomy
Wall Street Analysts Predict a 437.05% Upside in Sagimet Biosciences Inc. (SGMT): Here's What You Should Know - MSN
Sagimet Biosciences’ SWOT analysis: promising FASN inhibitor stock faces funding hurdles By Investing.com - Investing.com South Africa
Sagimet Biosciences’ SWOT analysis: promising FASN inhibitor stock faces funding hurdles - Investing.com
Analysts Offer Insights on Healthcare Companies: Pfizer (PFE) and Sagimet Biosciences, Inc. Class A (SGMT) - The Globe and Mail
Sagimet stock holds steady as JMP reiterates $31 price target By Investing.com - Investing.com Nigeria
Sagimet Biosciences Inc: Analyzing SGMT Stock Trends - investchronicle.com
Sagimet Biosciences Soars 10.6% on Upgraded Price Target - AInvest
Sagimet Biosciences Plunges 11.73% Amid Acne Treatment Updates - AInvest
Two Sigma Investments LP Trims Holdings in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World
What Makes Sagimet Biosciences Inc. (SGMT) a Strong Momentum Stock: Buy Now? - Yahoo Finance
Sagimet Biosciences updates executive compensation By Investing.com - Investing.com South Africa
Sagimet Biosciences updates executive compensation - Investing.com
Sagimet Biosciences Elects New Directors at Annual Meeting - TipRanks
Sagimet Biosciences to Host Virtual KOL Event, “A New - GlobeNewswire
Sagimet Biosciences to host KOL event on denifanstat results - TipRanks
Sagimet Biosciences (SGMT) to Highlight Positive Phase 3 Acne Treatment Results | SGMT Stock News - GuruFocus
Sagimet Biosciences to Host Virtual KOL Event, 'A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June 16, 2025 - The Manila Times
Sagimet Biosciences to Host Virtual KOL Event, “A New Mechanism of Action in Treating Acne: Update on Positive Phase 3 Denifanstat Trial for the Treatment of Moderate to Severe Acne” on June 16, 2025 - GlobeNewswire
Breakthrough Phase 3 Results: Novel Oral Acne Drug Shows Promise for 50M US Patients - Stock Titan
Analysts Set Sagimet Biosciences Inc. (NASDAQ:SGMT) PT at $23.17 - Defense World
Squarepoint Ops LLC Grows Stake in Sagimet Biosciences Inc. (NASDAQ:SGMT) - Defense World
Sagimet Biosciences (NASDAQ:SGMT) Stock Price Expected to Rise, Jones Trading Analyst Says - Defense World
Sagimet Biosciences Inc (SGMT) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.37%
0.07%
자본화:
|
볼륨(24시간):